Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1994-7-11
|
pubmed:abstractText |
The charts of 147 patients with advanced ovarian cancers responding completely (CR) or partially (PR > 50%) to a primary cisplatin-based chemotherapy are reviewed. All fulfilled our criterias to undergo second-look laparotomy. One hundred patients (group A) underwent second-look laparotomy and 47 patients (group B) other features of control: laparoscopy 37 patients, clinical control ten patients. Apart metastatic spread more frequent in group B (A vs B = 10 vs 32%) and tumor grade 1 more frequent in group B (A vs B = 33 vs 49%), the two groups were well balanced concerning tumor characteristics and treatment features. All patients had received a complementary treatment after the second-look procedures. With a median follow-up of 86 months in group A and 104 months in group B, no difference was found in overall nor in recurrence-free survival. Within group A, 34 patients had achieved pathologic proved complete remission. Their 5-year survival was 73% with an incidence of recurrence of 32%. Second-look laparotomy was found an invasive technique with a 15% operative morbidity. Its therapeutic apport seems absent and the diagnostic role limited to indication of radiotherapy in CR patients. Second-look laparotomies should be reserved to trials evaluating its proper place but should not be used systematically to assess tumor response to chemotherapy. The good 5-year survival of the CR mi group suggest the beneficial impact of complementary treatment, but prospective trials are needed to evaluate the place of this treatment.
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0007-4551
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
80
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
629-38
|
pubmed:dateRevised |
2009-11-11
|
pubmed:meshHeading |
pubmed-meshheading:8204944-Adult,
pubmed-meshheading:8204944-Aged,
pubmed-meshheading:8204944-Cisplatin,
pubmed-meshheading:8204944-Female,
pubmed-meshheading:8204944-Follow-Up Studies,
pubmed-meshheading:8204944-Humans,
pubmed-meshheading:8204944-Laparoscopy,
pubmed-meshheading:8204944-Laparotomy,
pubmed-meshheading:8204944-Middle Aged,
pubmed-meshheading:8204944-Neoplasm Staging,
pubmed-meshheading:8204944-Ovarian Neoplasms,
pubmed-meshheading:8204944-Remission Induction,
pubmed-meshheading:8204944-Reoperation,
pubmed-meshheading:8204944-Retrospective Studies,
pubmed-meshheading:8204944-Survival Rate
|
pubmed:year |
1993
|
pubmed:articleTitle |
[Is there a place for 2nd look laparotomy in the treatment of ovarian cancers?].
|
pubmed:affiliation |
Service de chirurgie, fondation Bergonié, Bordeaux, France.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract
|